Morgan Stanley’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$873K Buy
231,589
+42,563
+23% +$160K ﹤0.01% 5172
2025
Q1
$856K Sell
189,026
-66,266
-26% -$300K ﹤0.01% 5078
2024
Q4
$1.8M Sell
255,292
-51,095
-17% -$361K ﹤0.01% 4774
2024
Q3
$2.49M Sell
306,387
-136,756
-31% -$1.11M ﹤0.01% 4492
2024
Q2
$2.83M Sell
443,143
-32,501
-7% -$208K ﹤0.01% 4330
2024
Q1
$3.58M Sell
475,644
-897,684
-65% -$6.76M ﹤0.01% 4183
2023
Q4
$12.7M Buy
1,373,328
+976,399
+246% +$9.04M ﹤0.01% 3723
2023
Q3
$4.02M Sell
396,929
-58,285
-13% -$590K ﹤0.01% 3906
2023
Q2
$5.69M Buy
455,214
+2,219
+0.5% +$27.7K ﹤0.01% 3674
2023
Q1
$5.29M Sell
452,995
-265,158
-37% -$3.09M ﹤0.01% 3740
2022
Q4
$7.63M Buy
718,153
+198,040
+38% +$2.11M ﹤0.01% 3342
2022
Q3
$5.04M Buy
520,113
+75,291
+17% +$730K ﹤0.01% 3686
2022
Q2
$6.45M Buy
444,822
+324,779
+271% +$4.71M ﹤0.01% 3517
2022
Q1
$3.14M Sell
120,043
-142,706
-54% -$3.73M ﹤0.01% 4158
2021
Q4
$10.4M Sell
262,749
-67,264
-20% -$2.66M ﹤0.01% 2912
2021
Q3
$16.5M Sell
330,013
-46,933
-12% -$2.35M ﹤0.01% 2297
2021
Q2
$20.9M Buy
376,946
+135,194
+56% +$7.5M ﹤0.01% 2102
2021
Q1
$11.3M Sell
241,752
-73,970
-23% -$3.46M ﹤0.01% 2522
2020
Q4
$13.7M Buy
315,722
+85,651
+37% +$3.73M ﹤0.01% 2187
2020
Q3
$8.42M Sell
230,071
-117,942
-34% -$4.32M ﹤0.01% 2180
2020
Q2
$10.2M Buy
348,013
+301,881
+654% +$8.81M ﹤0.01% 1952
2020
Q1
$1.21M Buy
46,132
+4,271
+10% +$112K ﹤0.01% 3809
2019
Q4
$1.45M Buy
41,861
+33,554
+404% +$1.16M ﹤0.01% 4272
2019
Q3
$263K Buy
+8,307
New +$263K ﹤0.01% 4996